UBS O'Connor’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,422
| Closed | -$224K | – | 325 |
|
|
2025
Q1 | $224K | Buy |
21,422
+8,838
| +70% | +$92.4K | 0.01% | 217 |
|
|
2024
Q4 | $296K | Sell |
12,584
-6,734
| -35% | -$159K | 0.01% | 293 |
|
|
2024
Q3 | $694K | Sell |
19,318
-13,626
| -41% | -$489K | 0.02% | 311 |
|
|
2024
Q2 | $1.16M | Sell |
32,944
-181
| -0.5% | -$6.39K | 0.03% | 272 |
|
|
2024
Q1 | $940K | Sell |
33,125
-24,205
| -42% | -$687K | 0.03% | 277 |
|
|
2023
Q4 | $762K | Sell |
57,330
-53,422
| -48% | -$711K | 0.02% | 295 |
|
|
2023
Q3 | $992K | Sell |
110,752
-65,000
| -37% | -$582K | 0.02% | 325 |
|
|
2023
Q2 | $1.98M | Sell |
175,752
-849
| -0.5% | -$9.55K | 0.04% | 294 |
|
|
2023
Q1 | $2.03M | Buy |
+176,601
| New | +$2.03M | 0.05% | 307 |
|
|
2022
Q4 | – | Sell |
-176,490
| Closed | -$2.24M | – | 93 |
|
|
2022
Q3 | $2.24M | Sell |
176,490
-50,868
| -22% | -$646K | 0.03% | 607 |
|
|
2022
Q2 | $1.56M | Buy |
+227,358
| New | +$1.56M | 0.02% | 694 |
|